The neuropeptide neuromedin U promotes autoantibody-mediated arthritis

Arthritis Research and Therapy

Volumn 14, Issue 1, 2012, Pages

  Rao, Sindhuja M ^a,b   Auger, Jennifer L ^a   Gaillard, Philippe ^c   Weissleder, Ralph ^d   Wada, Etsuko ^e   Torres, Richard ^f   Kojima, Masayasu ^g   Benoist, Christophe ^h   Mathis, Diane ^h   Binstadt, Bryce A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^f REGENERON PHARMACEUTICALS INC   (United States)

^g KURUME UNIVERSITY   (Japan)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALCIUM; NEUROMEDIN U; ISOPROTEIN; NEUROMEDIN U RECEPTOR; NEUROPEPTIDE; NEUROTENSIN RECEPTOR; NEUROTENSIN TYPE 1 RECEPTOR; NEUROTRANSMITTER RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BONE MARROW; CALCIUM TRANSPORT; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; HEMATOPOIETIC CELL; IN VITRO STUDY; MAST CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STROMA CELL; ANIMAL; BONE MARROW CELL; C57BL MOUSE; FEMALE; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; SPLEEN; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS; AUTOANTIBODIES; BONE MARROW CELLS; CALCIUM; FEMALE; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, TRANSGENIC; NEUROPEPTIDES; PROTEIN ISOFORMS; RECEPTORS, NEUROTENSIN; RECEPTORS, NEUROTRANSMITTER; SPLEEN;

EID: 84856578745     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3732     Document Type: Article

References (34)

1. Budhiraja S, Chugh A. Neuromedin U: physiology, pharmacology and therapeutic potential. Fundam Clin Pharmacol 2009, 23:149-157. 10.1111/j.1472-8206.2009.00667.x, 19645813.
2. Domin J, Ghatei MA, Chohan P, Bloom SR. Neuromedin U--a study of its distribution in the rat. Peptides 1987, 8:779-784. 10.1016/0196-9781(87)90058-1, 3432125.
3. Brighton PJ, Szekeres PG, Willars GB. Neuromedin U and its receptors: structure, function, and physiological roles. Pharmacol Rev 2004, 56:231-248. 10.1124/pr.56.2.3, 15169928.
4. Funes S, Hedrick JA, Yang S, Shan L, Bayne M, Monsma FJ, Gustafson EL. Cloning and characterization of murine neuromedin U receptors. Peptides 2002, 23:1607-1615. 10.1016/S0196-9781(02)00097-9, 12217421.
5. Johnson EN, Appelbaum ER, Carpenter DC, Cox RF, Disa J, Foley JJ, Ghosh SK, Naselsky DP, Pullen MA, Sarau HM, Scheff SR, Steplewski KM, Zaks-Zilberman M, Aiyar N. Neuromedin U elicits cytokine release in murine Th2-type T cell clone D10.G4.1. J Immunol 2004, 173:7230-7238.
6. Moriyama M, Sato T, Inoue H, Fukuyama S, Teranishi H, Kangawa K, Kano T, Yoshimura A, Kojima M. The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells. J Exp Med 2005, 202:217-224. 10.1084/jem.20050248, 2213011, 16009716.
7. Moriyama M, Fukuyama S, Inoue H, Matsumoto T, Sato T, Tanaka K, Kinjyo I, Kano T, Yoshimura A, Kojima M. The neuropeptide neuromedin U activates eosinophils and is involved in allergen-induced eosinophilia. Am J Physiol Lung Cell Mol Physiol 2006, 290:L971-977. 10.1152/ajplung.00345.2005, 16373672.
8. Moriyama M, Matsukawa A, Kudoh S, Takahashi T, Sato T, Kano T, Yoshimura A, Kojima M. The neuropeptide neuromedin U promotes IL-6 production from macrophages and endotoxin shock. Biochem Biophys Res Commun 2006, 341:1149-1154. 10.1016/j.bbrc.2006.01.075, 16466693.
9. Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, Takahashi K, Holers VM, Walport M, Gerard C, Ezekowitz A, Carroll MC, Brenner M, Weissleder R, Verbeek JS, Duchatelle V, Degott C, Benoist C, Mathis D. Arthritis critically dependent on innate immune system players. Immunity 2002, 16:157-168. 10.1016/S1074-7613(02)00275-3, 11869678.
10. Ji H, Pettit A, Ohmura K, Ortiz-Lopez A, Duchatelle V, Degott C, Gravallese E, Mathis D, Benoist C. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med 2002, 196:77-85. 10.1084/jem.20020439, 2194010, 12093872.
11. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002, 297:1689-1692. 10.1126/science.1073176, 12215644.
12. Monach P, Hattori K, Huang H, Hyatt E, Morse J, Nguyen L, Ortiz-Lopez A, Wu HJ, Mathis D, Benoist C. The K/BxN mouse model of inflammatory arthritis: theory and practice. Methods Mol Med 2007, 136:269-282. 10.1007/978-1-59745-402-5_20, 17983155.
13. Monach PA, Nigrovic PA, Chen M, Hock H, Lee DM, Benoist C, Mathis D. Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor gamma, the receptor for C5a, and lymphocyte function-associated antigen 1. Arthritis Rheum 2010, 62:753-764. 10.1002/art.27238, 3057458, 20191628.
14. Wipke BT, Allen PM. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol 2001, 167:1601-1608.
15. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O'Donnell E, Farndale RW, Ware J, Lee DM. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010, 327:580-583. 10.1126/science.1181928, 2927861, 20110505.
16. Corr M, Crain B. The role of FcgammaR signaling in the K/B × N serum transfer model of arthritis. J Immunol 2002, 169:6604-6609.
17. Nimmerjahn F, Lux A, Albert H, Woigk M, Lehmann C, Dudziak D, Smith P, Ravetch JV. FcgammaRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo. Proc Natl Acad Sci USA 2010, 107:19396-19401. 10.1073/pnas.1014515107, 2984189, 20974962.
18. Hanada R, Teranishi H, Pearson JT, Kurokawa M, Hosoda H, Fukushima N, Fukue Y, Serino R, Fujihara H, Ueta Y, Ikawa M, Okabe M, Murakami N, Shirai M, Yoshimatsu H, Kangawa K, Kojima M. Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway. Nat Med 2004, 10:1067-1073. 10.1038/nm1106, 15448684.
19. Maeno H, Yamada K, Santo-Yamada Y, Aoki K, Sun YJ, Sato E, Fukushima T, Ogura H, Araki T, Kamichi S, Kimura I, Yamano M, Maeno-Hikichi Y, Watase K, Aoki S, Kiyama H, Wada E, Wada K. Comparison of mice deficient in the high- or low-affinity neurotensin receptors, Ntsr1 or Ntsr2, reveals a novel function for Ntsr2 in thermal nociception. Brain Res 2004, 998:122-129. 10.1016/j.brainres.2003.11.039, 14725975.
20. Torres R, Croll SD, Vercollone J, Reinhardt J, Griffiths J, Zabski S, Anderson KD, Adams NC, Gowen L, Sleeman MW, Valenzuela DM, Wiegand SJ, Yancopoulos GD, Murphy AJ. Mice genetically deficient in neuromedin U receptor 2, but not neuromedin U receptor 1, have impaired nociceptive responses. Pain 2007, 130:267-278. 10.1016/j.pain.2007.01.036, 17379411.
21. Mouse Genome Informatics. , http://www.informatics.jax.org
22. Binstadt BA, Patel PR, Alencar H, Nigrovic PA, Lee DM, Mahmood U, Weissleder R, Mathis D, Benoist C. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol 2006, 7:284-292. 10.1038/ni1306, 16444258.
23. Binstadt BA, Hebert JL, Ortiz-Lopez A, Bronson R, Benoist C, Mathis D. The same systemic autoimmune disease provokes arthritis and endocarditis via distinct mechanisms. Proc Natl Acad Sci USA 2009, 106:16758-16763. 10.1073/pnas.0909132106, 2757808, 19805369.
24. Wipke BT, Wang Z, Kim J, McCarthy TJ, Allen PM. Dynamic visualization of a joint-specific autoimmune response through positron emission tomography. Nat Immunol 2002, 3:366-372. 10.1038/ni775, 11896393.
25. Wipke BT, Wang Z, Nagengast W, Reichert DE, Allen PM. Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J Immunol 2004, 172:7694-7702.
26. Mancardi DA, Jonsson F, Iannascoli B, Khun H, Van Rooijen N, Huerre M, Daeron M, Bruhns P. The murine high-affinity IgG receptor FcgammaRIV is sufficient for autoantibody-induced arthritis. J Immunol 2011, 186:1899-1903. 10.4049/jimmunol.1003642, 21248252.
27. Elliott ER, Van Ziffle JA, Scapini P, Sullivan BM, Locksley RM, Lowell CA. Deletion of syk in neutrophils prevents immune complex arthritis. J Immunol 2011, 187:4319-4330. 10.4049/jimmunol.1100341, 21918195.
28. Takahashi K, Furukawa C, Takano A, Ishikawa N, Kato T, Hayama S, Suzuki C, Yasui W, Inai K, Sone S, Ito T, Nishimura H, Tsuchiya E, Nakamura Y, Daigo Y. The neuromedin U-growth hormone secretagogue receptor 1 b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer. Cancer Res 2006, 66:9408-9419. 10.1158/0008-5472.CAN-06-1349, 17018595.
29. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol 2004, 201:167-180. 10.1002/jcp.20061, 15334652.
30. Capellino S, Cosentino M, Wolff C, Schmidt M, Grifka J, Straub RH. Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target. Ann Rheum Dis 2010, 69:1853-1860. 10.1136/ard.2009.119701, 20498218.
31. Hedrick JA, Morse K, Shan L, Qiao X, Pang L, Wang S, Laz T, Gustafson EL, Bayne M, Monsma FJ. Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U. Mol Pharmacol 2000, 58:870-875.
32. Wheway J, Herzog H, Mackay F. NPY and receptors in immune and inflammatory diseases. Curr Top Med Chem 2007, 7:1743-1752. 10.2174/156802607782341046, 17979783.
33. Prendergast CE, Morton MF, Figueroa KW, Wu X, Shankley NP. Species-dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout mice. Br J Pharmacol 2006, 147:886-896. 10.1038/sj.bjp.0706677, 1760708, 16474416.
34. Kim ER, Mizuno TM. Role of neurotensin receptor 1 in the regulation of food intake by neuromedins and neuromedin-related peptides. Neurosci Lett 2010, 468:64-67. 10.1016/j.neulet.2009.10.064, 19857548.